Published in Science on June 10, 1988
Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. Proc Natl Acad Sci U S A (1990) 5.85
Errors and alternatives in reading the universal genetic code. Microbiol Rev (1989) 4.67
Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol (1995) 3.96
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev (2008) 3.07
Engineering lymphocyte subsets: tools, trials and tribulations. Nat Rev Immunol (2009) 3.06
Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro. Mol Cell Biol (1989) 3.00
U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci U S A (1990) 2.90
Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J Virol (1992) 2.89
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci U S A (1991) 2.74
Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells. J Virol (1996) 2.70
Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc Natl Acad Sci U S A (1994) 2.56
Sequence of the circle junction of human immunodeficiency virus type 1: implications for reverse transcription and integration. J Virol (1990) 2.24
Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol (1993) 2.08
A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol Cell Biol (1997) 2.07
Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: relation to primate retroviruses. J Virol (1989) 2.05
Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences. J Virol (1991) 1.91
Identification of cellular promoters by using a retrovirus promoter trap. J Virol (1989) 1.79
Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol (1994) 1.77
Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. Proc Natl Acad Sci U S A (1994) 1.74
Analysis of mutations at position 184 in reverse transcriptase of human immunodeficiency virus type 1. Antimicrob Agents Chemother (1995) 1.71
Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J Virol (1992) 1.69
Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc Natl Acad Sci U S A (1990) 1.63
Identification of a U5-specific sequence required for efficient polyadenylation within the human immunodeficiency virus long terminal repeat. J Virol (1989) 1.61
Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation. J Exp Med (1989) 1.59
Retrovirus infection: effect of time and target cell number. J Virol (1995) 1.51
Insertion bias and purifying selection of retrotransposons in the Arabidopsis thaliana genome. Genome Biol (2004) 1.50
Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1992) 1.48
A brief history of the status of transposable elements: from junk DNA to major players in evolution. Genetics (2010) 1.42
Tempo and mode of Ty element evolution in Saccharomyces cerevisiae. Genetics (1999) 1.41
A rapidly rearranging retrotransposon within the miniexon gene locus of Crithidia fasciculata. Mol Cell Biol (1990) 1.41
Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1994) 1.40
The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys. J Virol (1994) 1.36
Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J Virol (1994) 1.29
Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys). Nucleic Acids Res (1990) 1.28
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy. Expert Opin Biol Ther (2011) 1.27
Thermodynamic stability and statistical significance of potential stem-loop structures situated at the frameshift sites of retroviruses. Nucleic Acids Res (1989) 1.26
Extended interactions between the primer tRNAi(Met) and genomic RNA of the yeast Ty1 retrotransposon. Nucleic Acids Res (1996) 1.26
Differential response to frameshift signals in eukaryotic and prokaryotic translational systems. Nucleic Acids Res (1993) 1.25
Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol (1996) 1.21
Characterization of the gag/fusion protein encoded by the defective Duplan retrovirus inducing murine acquired immunodeficiency syndrome. J Virol (1990) 1.20
Isolation of virus-neutralizing RNAs from a large pool of random sequences. Proc Natl Acad Sci U S A (1995) 1.18
Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc Natl Acad Sci U S A (1998) 1.17
The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci U S A (1996) 1.17
flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J Virol (1990) 1.15
cDNA sequence and genomic characterization of intracisternal A-particle-related retroviral elements containing an envelope gene. J Virol (1991) 1.14
Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol Cell Biol (1990) 1.12
Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP. Nucleic Acids Res (1989) 1.12
Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. Nucleic Acids Res (2008) 1.10
The Mlvi-1 locus involved in the induction of rat T-cell lymphomas and the pvt-1/Mis-1 locus are identical. J Virol (1989) 1.10
Yeast Ty1 retrotransposon: the minus-strand primer binding site and a cis-acting domain of the Ty1 RNA are both important for packaging of primer tRNA inside virus-like particles. Nucleic Acids Res (1994) 1.08
Rex transregulation of human T-cell leukemia virus type II gene expression. J Virol (1991) 1.07
Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells. J Virol (1991) 1.07
Translation of the rat LINE bicistronic RNAs in vitro involves ribosomal reinitiation instead of frameshifting. Mol Cell Biol (1992) 1.06
Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review). Int J Oncol (2012) 1.05
Isolation of cellular promoters by using a retrovirus promoter trap. Proc Natl Acad Sci U S A (1990) 1.05
Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J Virol (1993) 1.04
Interactions between Ty1 retrotransposon RNA and the T and D regions of the tRNA(iMet) primer are required for initiation of reverse transcription in vivo. Mol Cell Biol (1998) 1.03
Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. EMBO J (1990) 1.02
Self-deleting retrovirus vectors for gene therapy. J Virol (1996) 1.01
Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase-elevating virus in motor neurons. J Virol (1989) 0.99
Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice. J Virol (1992) 0.99
Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. Am J Pathol (1993) 0.98
Genomic demography: a life-history analysis of transposable element evolution. Proc Biol Sci (1999) 0.97
Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements. J Virol (1998) 0.97
In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription. Nucleic Acids Res (1992) 0.96
Jaagsiekte sheep retrovirus biology and oncogenesis. Viruses (2010) 0.96
Characterisation of LTR sequences involved in the protoplast specific expression of the tobacco Tnt1 retrotransposon. Nucleic Acids Res (1993) 0.94
Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis. J Virol (2003) 0.93
Selective activation of a discrete family of endogenous proviral elements in normal BALB/c lymphocytes. Mol Cell Biol (1992) 0.93
A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector. J Virol (2003) 0.92
Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination. Proc Natl Acad Sci U S A (1996) 0.91
Retrovirus-induced interference with collagen I gene expression in Mov13 fibroblasts is maintained in the absence of DNA methylation. Mol Cell Biol (1991) 0.90
Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer. J Virol (2001) 0.89
Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in São Paulo, Brazil. Virol J (2010) 0.89
Nucleotide modification at the gamma-phosphate leads to the improved fidelity of HIV-1 reverse transcriptase. Nucleic Acids Res (2005) 0.89
Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes. Exp Dermatol (2005) 0.88
Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus. J Virol (1992) 0.88
Analysis of Moloney murine leukemia virus revertants mutated at the gag-pol junction. J Virol (1991) 0.87
Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNA. J Virol (1996) 0.87
CAR-T Cell Therapy for Lymphoma. Annu Rev Med (2015) 0.86
Cardiovascular gene delivery: The good road is awaiting. Adv Drug Deliv Rev (2006) 0.85
Down modulation of HIV-1 gene expression using a procaryotic RNA-binding protein. Nucleic Acids Res (1990) 0.84
Immunological characterization of the gag gene products of bovine immunodeficiency virus. J Virol (1992) 0.84
Heterogeneous terminal structure of Ty1 and Ty3 reverse transcripts. Nucleic Acids Res (1997) 0.84
Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression. J Exp Med (1989) 0.83
Unusual features of the retroid element PAT from the nematode Panagrellus redivivus. Nucleic Acids Res (1992) 0.83
Simian immunodeficiency virus in which nef and U3 sequences do not overlap replicates efficiently in vitro and in vivo in rhesus macaques. J Virol (2001) 0.83
Contrasted cis-acting effects of downstream 5' splice sites on the splicing of a retained intron: the adenoviral E1A pre-mRNA model. Nucleic Acids Res (1993) 0.82
Frameshifting in the expression of the Escherichia coli trpR gene is modulated by translation initiation. J Bacteriol (1993) 0.78
Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination. Anticancer Res (2010) 0.78
TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression. PLoS One (2012) 0.77
Development of high-titer retroviral producer cell lines by using Cre-mediated recombination. J Virol (1997) 0.77
Characterization of Kaposi's Sarcoma-Associated Herpesvirus-Related Lymphomas by DNA Microarray Analysis. Leuk Res Treatment (2011) 0.77
C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection. Appl Transl Genom (2013) 0.76
Retroviruses as genetic tools to isolate transcriptionally active chromosomal regions. Environ Health Perspect (1990) 0.75
HTLV-1: A Significant Retrovirus. Can Fam Physician (1988) 0.75
Characterization of retroviral infectivity and superinfection resistance during retrovirus-mediated transduction of mammalian cells. Gene Ther (2017) 0.75